<DOC>
	<DOCNO>NCT01426828</DOCNO>
	<brief_summary>This study enroll myeloma subject undergoing autotransplantation . The primary objective study evaluate whether infusion Id-KLH prim CD3/CD28 activate autologous lymphocyte mediate intense Id-specific immunity non Id-KLH prim CD3/CD28 activate autologous lymphocyte . There 2 arm study , one receiving DLI non Id-KLH vaccine one receiving aDLI Id-KLH vaccine .</brief_summary>
	<brief_title>Id-KLH Vaccine + T Cells</brief_title>
	<detailed_description>The primary objective study evaluate whether infusion Id-KLH prim CD3/CD28 activate autologous lymphocyte mediate intense id-specific immunity non id-KLH primed CD3/CD28 activate autologous lymphocyte . The secondary objective study demonstrate dos 1 time 10e10 Id-KLH prim CD3/CD28 autologous lymphocyte infuse safely effectively 80 percent eligible patient , determine whether Id-KLH prim CD3/CD28 activate autologous lymphocyte determine presence Id-specific immunity correlate disease response .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>SCREEN # 1 ( Visit 1 ) Step 1 : Diagnosis symptomatic multiple myeloma . Less 10 month initiation systemic therapy . One two line induction therapy commonly use regimen . Age great equal 18 year less equal 70 year time enrollment . IgG paraprotein ( IgG3 subtype ) paraprotein peak ( Mspike ) â‰¥0.2 g/dL . Alternatively subject previously store purify Idspecific protein clinical laboratory protocol . Echocardiogram MUGA ejection fraction 45 % uncompensated congestive heart failure uncontrolled arrhythmia . Adequate pulmonary function define FEV1 , FVC actual correct DLCO 50 % great predict value age , sex size . Adequate renal function define creatinine 2.0 mg/dl less creatinine clearance 40cc/min . Adequate hepatic function define total bilirubin 2.0 mg/dl less AST ALT less 2 time upper limit normal . Ability sign write informed consent . Karnofsky performance status least 80 % . Negative serum Beta HCG test woman child bear potential agree use medically acceptable form birth control study drug . Exclusion : Subjects melphalanbased induction Active uncontrolled infection HIV+ active hepatitis B C define positive viral load serology . Preexisting autoimmune disease , exception Hashimoto 's thyroiditis . Concurrent use systemic steroid time cell infusion cell collection , condition , treat physician 's opinion , likely require steroid therapy Tcell collection infusion . Steroids disease treatment time cell collection time infusion permit . Use inhale steroid permit well . Prior autologous allogeneic transplant . For study , exception eligibility grant . 4.2 PREVACCINE # 1 ASSESSMENT ( Visit 3 ) Step 2 Subjects must meet follow criterion proceed vaccination : Less 9 month randomization . Adequate renal function define creatinine 2.0 mg/dl less creatinine clearance 40cc/min . Adequate hepatic function define total bilirubin 2.0 mg/dl less AST ALT less 2 time upper limit normal . Karnofsky performance status least 80 % . At least 2 week last chemotherapy . Negative serum Beta HCG test woman child bear potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>adult</keyword>
	<keyword>symptomatic multiple myeloma</keyword>
	<keyword>myeloma</keyword>
	<keyword>diagnosis within 12 month initiation systemic therapy</keyword>
</DOC>